A Study on the Relationship Between the Abnormal Expression of TGF-β_1, TGF-βRIand Malignant Biological Behaviors in Ovarian Carcinoma
Xu Hua
Abstract
Xu Hua
Abstract
Objective To investigate the expression and significance of transforming growth factor-beta1(TGF-β 1),transforming growth factor-beta receptor typeⅠ(TGF-β RⅠ) in human ovarian carcinoma. Methods Inmmunohistochemical SP method was used to detect the expression of TGF-β 1 and TGF-β RI in 85 cases of benign and malignant ovarian tumors. Results The positive rate of TGF-β 1 in benign and malignant ovarian tumors was significantly higher than that in the normal ovarian tissues(P0.05); The frequency of TGF-β RⅠ middle and strong positive expression was remarkably lower in the malignant tumours than that in the benign ovarian tumors and normal ovarian tissues(P0.05). The abnormal expression of TGF-β 1 and TGF-β RⅠ was obviously associated with the clinical stages of ovarian carcinoma, but not with patients ages and ascites. TGF-β 1 was related to the histological type of malignant ovarian tumors, and negatively related with pathological staging and metastasis of ovarian carcinoma. Conclusion The abnormal expression of TGF-β 1 and TGF-β RⅠ was associated with the malignant biological behaviors in ovarian tumours, and may serve as a marker for predicting the prognosis of ovarian cancers. TGF-β 1 and TGF-β RⅠ may play an important role in the pathogenesis of ovarian carcinoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the expression and significance of transforming growth factor-beta1(TGF-β 1),transforming growth factor-beta receptor typeⅠ(TGF-β RⅠ) in human ovarian carcinoma. Methods Inmmunohistochemical SP method was used to detect the expression of TGF-β 1 and TGF-β RI in 85 cases of benign and malignant ovarian tumors. Results The positive rate of TGF-β 1 in benign and malignant ovarian tumors was significantly higher than that in the normal ovarian tissues(P0.05); The frequency of TGF-β RⅠ middle and strong positive expression was remarkably lower in the malignant tumours than that in the benign ovarian tumors and normal ovarian tissues(P0.05). The abnormal expression of TGF-β 1 and TGF-β RⅠ was obviously associated with the clinical stages of ovarian carcinoma, but not with patients ages and ascites. TGF-β 1 was related to the histological type of malignant ovarian tumors, and negatively related with pathological staging and metastasis of ovarian carcinoma. Conclusion The abnormal expression of TGF-β 1 and TGF-β RⅠ was associated with the malignant biological behaviors in ovarian tumours, and may serve as a marker for predicting the prognosis of ovarian cancers. TGF-β 1 and TGF-β RⅠ may play an important role in the pathogenesis of ovarian carcinoma.
Key concepts: Ovarian carcinoma, Transforming growth factor, Ovarian cancer, Ascites, Pathological, Medicine, Metastasis, Carcinoma